SECRETARIAT

Bernardo Sorj
Ilona Szabó de Carvalho
Miguel Darcy de Oliveira

ADVISORS
Dr. Alex Wodak, Australian Drug Law
Reform Foundation
www.adlrf.org.au
Ethan Nadelmann, Drug Policy Alliance
www.drugpolicy.org
Martin Jelsma, Transnational Institute
www.tni.org/drugs
Mike Trace, International Drug Policy Consortium
www.idpc.net

SUPPORT
Centro Edelstein de Pesquisas Sociais
Instituto Fernando Henrique Cardoso
Open Society Foundations
Sir Richard Branson, founder and chairman of
Virgin Group (Support provided through
Virgin Unite)

BACKGROUND PAPERS
(available at www.globalcommissionondrugs.org)
Demand reduction and harm reduction
Dr. Alex Wodak
Drug policy, criminal justice and mass imprisonment
Bryan Stevenson
Assessing supply-side policy and practice: eradication and alternative development
David Mansfield
The development of international drug control: lessons learned and strategic challenges for the future
Martin Jelsma
Drug policy: lessons learned and options for the future
Mike Trace
The drug trade: the politicization of criminals and
the criminalization of politicians
Moisés Naím

FOR ADDITIONAL RESOURCES, SEE:
www.unodc.org
www.idpc.net
www.drugpolicy.org
www.talkingdrugs.org
www.tni.org/drugs
www.ihra.net
www.countthecosts.org
www.intercambios.org.ar
www.cupihd.org
www.wola.org/program/drug_policy
www.beckleyfoundation.org
www.comunidadesegura.org

GLOBAL COMMISSION ON DRUG POLICY

The purpose of the Global Commission on Drug Policy is to bring to the international level an informed, science-based discussion about humane and effective ways to reduce the harm caused by drugs to people and societies.

GOALS

• Review the basic assumptions, effectiveness and consequences of the ‘war on drugs’ approach
• Evaluate the risks and benefits of different national responses to the drug problem
• Develop actionable, evidence-based recommendations for constructive legal and policy reform